Chart calendar Gilead Sciences, Inc.

d52f66cc35e02ec0.L8SiKmHt5V-GMZKYRtASeHyABiM-RQjbJtxHUdEbbm4.R4XTRTDZ1DSrUPm1JJN0NBLYP0B8dnCha78vIbRNKFx3ie5zPrrSBuJT3w~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2024-12-12 Détachement de
2025-02-11 04:02 pm Q4 2024 Earnings Release
2025-02-11 04:30 pm Q4 2024 Earnings Call
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)
2026-02-09 Q4 2025 Earnings Release (Projected)

Past events on Gilead Sciences, Inc.

Today 11:40 am Evercore ISI HealthCONx Conference
2024-12-03 11:00 am Piper Sandler Healthcare Conference
2024-11-20 04:30 am Jefferies London Healthcare Conference
2024-11-09 Drug Therapy International Congress
2024-11-06 04:30 pm Q3 2024 Earnings Call
2024-11-06 04:02 pm Q3 2024 Earnings Release
2024-09-12 Détachement de
2024-09-10 10:50 am Baird Global Healthcare Conference
2024-09-09 01:45 pm International Association for the Study of Lung Cancer World Conference - Abstract #OA08.07
2024-09-09 01:45 pm International Association for the Study of Lung Cancer World Conference - Abstract #OA08.06
2024-09-08 05:00 pm International Association for the Study of Lung Cancer World Conference - Abstract #OA04.04
2024-09-05 12:20 pm Morgan Stanley Healthcare Conference
2024-09-04 11:00 am Wells Fargo Healthcare Conference
2024-08-08 04:30 pm Q2 2024 Earnings Call
2024-08-08 04:02 pm Q2 2024 Earnings Release
2024-06-13 Détachement de
2024-06-12 01:20 pm Goldman Sachs Global Healthcare Conference
2024-06-05 11:00 am Jefferies Global Healthcare Conference
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No: #TPS8121
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No: #8592

Past dividends on Gilead Sciences, Inc.

2024-09-12 Quarterly 0.77 USD
2024-06-13 Quarterly 0.77 USD
2024-03-13 Quarterly 0.77 USD
2023-12-13 Quarterly 0.75 USD
2023-09-13 Quarterly 0.75 USD
2023-06-13 Quarterly 0.75 USD
2023-03-13 Quarterly 0.75 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.73 USD
2022-06-13 Quarterly 0.73 USD
2022-03-13 Quarterly 0.73 USD
2021-12-13 Quarterly 0.71 USD
2021-09-13 Quarterly 0.71 USD
2021-06-13 Quarterly 0.71 USD
2021-03-11 Quarterly 0.71 USD
2020-12-13 Quarterly 0.68 USD
2020-09-13 Quarterly 0.68 USD
2020-06-10 Quarterly 0.68 USD
2020-03-11 Quarterly 0.68 USD
2019-12-11 Quarterly 0.63 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
27 305
26 657
2.43%
27 281
26 518
2.88%
27 116
27 083
0.12%

28 305


28 294


29 171

EBITDA
Million USD
Released
Forecast
Spread
14 598
15 539
-6.05%
14 283
13 783
3.63%
13 177
13 123
0.41%

10 714


14 625


15 001

EBIT
Million USD
Released
Forecast
Spread
12 548
13 943
-10.01%
12 180
12 141
0.32%
10 484
10 687
-1.9%

8 251


12 394


12 889

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8 278
9 507
-12.92%
5 814
5 658
2.76%
6 859
7 323
-6.33%

498


8 429


8 908

Net income
Million USD
Released
Forecast
Spread
6 225
7 205
-13.6%
4 592
4 383
4.77%
5 665
5 872
-3.52%

259


6 921


7 527

EPS
USD
Released
Forecast
Spread
4,93
5,75
-14.19%
3,64
3,48
4.75%
4,50
4,69
-3.96%

0,13


5,66


6,15

Announcement Date01/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
6 352
6 326
0.41%
6 599
6 454
2.24%
7 051
6 800
3.69%
7 115
7 104
0.16%
6 686
6 349
5.31%
6 954
6 735
3.25%
7 545
6 999
7.8%

7 163


6 641


6 859


7 294


7 486

EBITDA
Million USD
Released
Forecast
Spread
2 883
3 407
-15.38%
3 258
3 343
-2.54%
3 908
3 636
7.49%
3 427
3 495
-1.94%
-427
-889
51.98%
3 959
3 365
17.67%
3 948
3 498
12.86%

3 197













EBIT
Million USD
Released
Forecast
Spread
2 243
2 658
-15.62%
2 277
2 776
-17.99%
3 224
3 060
5.37%
2 739
2 940
-6.84%
-1 117
-1 679
33.48%
3 265
2 739
19.18%
3 258
2 721
19.75%

2 893


2 809


2 976


3 278


3 358

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 300
1 900
-31.59%
1 588
1 969
-19.35%
2 318
2 275
1.91%
1 653
2 090
-20.89%
-4 486


2 053
1 733
18.45%
956
1 652
-42.12%

2 043













Net income
Million USD
Released
Forecast
Spread
1 010
1 587
-36.37%
1 045
1 545
-32.38%
2 180
1 801
21.07%
1 429
1 599
-10.66%
-4 170
-2 888
-44.38%
1 614
1 379
17.02%
1 253
1 335
-6.15%

1 577


1 569


1 729


1 901


2 008

EPS
USD
Released
Forecast
Spread
0,80
1,23
-34.75%
0,83
1,20
-30.93%
1,73
1,43
20.88%
1,14
1,28
-11.05%
-3,34
-1,92
-74.06%
1,29
1,13
14.13%
1,00
1,08
-7.48%

1,37


1,27


1,44


1,65


1,69

Announcement Date27/04/2303/08/2307/11/2306/02/2425/04/2408/08/2406/11/24-----

Quarterly revenue - Rate of surprise

quality-estimates-chart GILEAD-SCIENCES-INC

Net sales - Rate of surprise

quality-estimates-chart GILEAD-SCIENCES-INC

Annual profits - Rate of surprise

quality-estimates-chart GILEAD-SCIENCES-INC
  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.
Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW